Align Aspartate aminotransferase; AAT; AspAT; Putative 2-aminoadipate transaminase; Transaminase A; EC 2.6.1.1; EC 2.6.1.39 (characterized)
to candidate CA265_RS07515 CA265_RS07515 pyridoxal phosphate-dependent aminotransferase
Query= SwissProt::P58350 (410 letters) >lcl|FitnessBrowser__Pedo557:CA265_RS07515 CA265_RS07515 pyridoxal phosphate-dependent aminotransferase Length = 380 Score = 312 bits (800), Expect = 9e-90 Identities = 166/383 (43%), Positives = 238/383 (62%), Gaps = 5/383 (1%) Query: 28 KIGARAAAMKREGKPVIILGAGEPDFDTPEHVKQAASDAIHRGETKYTALDGTPELKKAI 87 K+G A+ +G +I L GEPDF+TP+HVK AA A+ T+Y+ + G P+L++AI Sbjct: 3 KLGRELAS---KGINIISLSVGEPDFNTPDHVKNAAKKALDENYTRYSPVPGYPDLRQAI 59 Query: 88 REKFQRENGLAYELDEITVATGAKQILFNAMMASLDPGDEVIIPTPYWTSYSDIVHICEG 147 K + EN L Y++ +I V+TGAKQ L N ++ +DP DEVIIPTPYW SYS++V + EG Sbjct: 60 VNKLKTENNLDYDISQIVVSTGAKQSLSNVILTLIDPDDEVIIPTPYWVSYSEMVTLAEG 119 Query: 148 KPVLIACDASSGFRLTAEKLEAAITPRTRWVLLNSPSNPSGAAYSAADYRPLLEVLLRHP 207 K V I D S F++T +LEAAITP+++ + +SP NP+G+ YS + L+ V +HP Sbjct: 120 KSVFIDTDIESDFKITPAQLEAAITPKSKLFMFSSPCNPTGSVYSKEELAALVAVFEKHP 179 Query: 208 HVWLLVDDMYEHIVYDGFRFVTPAQLEPGLKNRTLTVNGVSKAYAMTGWRIGYAGGPREL 267 ++++L D++YEHI + + + AQ + +K+R + VNG SKA+AMTGWR+GY +E+ Sbjct: 180 NIYILSDEIYEHINFVD-KHESIAQFD-SIKDRVIIVNGFSKAFAMTGWRLGYIAANKEI 237 Query: 268 IKAMAVVQSQATSCPSSISQAASVAALNGPQDFLKERTESFQRRRDLVVNGLNAIDGLDC 327 A +Q Q TS SI+Q A + A + E E+F RRR+LV N LN I G+ Sbjct: 238 AAANDKLQGQTTSGTCSIAQRAGIVAYEQGLASVLEMKEAFLRRRELVYNLLNEIPGVKT 297 Query: 328 RVPEGAFYTFSGCAGVLGKVTPSGKRIKTDTDFCAYLLEDAHVAVVPGSAFGLSPFFRIS 387 +P+GAFY F + GK G IK +D YLL HVA V G +FG + + R+S Sbjct: 298 NLPDGAFYFFPEISSFFGKKDADGNVIKDSSDLALYLLNVGHVATVGGDSFGNNNYIRLS 357 Query: 388 YATSEAELKEALERIAAACDRLS 410 YA S+ L EAL RI A +L+ Sbjct: 358 YAASDESLVEALRRIKEALGKLA 380 Lambda K H 0.318 0.134 0.393 Gapped Lambda K H 0.267 0.0410 0.140 Matrix: BLOSUM62 Gap Penalties: Existence: 11, Extension: 1 Number of Sequences: 1 Number of Hits to DB: 372 Number of extensions: 16 Number of successful extensions: 2 Number of sequences better than 1.0e-02: 1 Number of HSP's gapped: 1 Number of HSP's successfully gapped: 1 Length of query: 410 Length of database: 380 Length adjustment: 31 Effective length of query: 379 Effective length of database: 349 Effective search space: 132271 Effective search space used: 132271 Neighboring words threshold: 11 Window for multiple hits: 40 X1: 16 ( 7.3 bits) X2: 38 (14.6 bits) X3: 64 (24.7 bits) S1: 41 (21.7 bits) S2: 50 (23.9 bits)
This GapMind analysis is from Sep 17 2021. The underlying query database was built on Sep 17 2021.
Each pathway is defined by a set of rules based on individual steps or genes. Candidates for each step are identified by using ublast (a fast alternative to protein BLAST) against a database of manually-curated proteins (most of which are experimentally characterized) or by using HMMer with enzyme models (usually from TIGRFam). Ublast hits may be split across two different proteins.
A candidate for a step is "high confidence" if either:
Otherwise, a candidate is "medium confidence" if either:
Other blast hits with at least 50% coverage are "low confidence."
Steps with no high- or medium-confidence candidates may be considered "gaps." For the typical bacterium that can make all 20 amino acids, there are 1-2 gaps in amino acid biosynthesis pathways. For diverse bacteria and archaea that can utilize a carbon source, there is a complete high-confidence catabolic pathway (including a transporter) just 38% of the time, and there is a complete medium-confidence pathway 63% of the time. Gaps may be due to:
GapMind relies on the predicted proteins in the genome and does not search the six-frame translation. In most cases, you can search the six-frame translation by clicking on links to Curated BLAST for each step definition (in the per-step page).
For more information, see the paper from 2019 on GapMind for amino acid biosynthesis, the paper from 2022 on GapMind for carbon sources, or view the source code.
If you notice any errors or omissions in the step descriptions, or any questionable results, please let us know
by Morgan Price, Arkin group, Lawrence Berkeley National Laboratory